COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study (ATLANREA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02714387
Recruitment Status : Recruiting
First Posted : March 21, 2016
Last Update Posted : September 15, 2017
Information provided by (Responsible Party):
Nantes University Hospital

Brief Summary:
The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.

Condition or disease Intervention/treatment
Non Traumatic Acute Brain Injury Other: Collection of medical data

Detailed Description:
Anonymous data will be collected by study coordinators in a secured e-database. Cross audit will be performed to check data.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 3000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Cohort of Patients Hospitalized in West French Intensive Care Units.
Study Start Date : February 2013
Estimated Primary Completion Date : January 2050
Estimated Study Completion Date : January 2050

Resource links provided by the National Library of Medicine

Group/Cohort Intervention/treatment
ICU patients
Patients with Non Traumatic Neuro-Vascular Diseases. Medical data concerning ICU stay will be collected.
Other: Collection of medical data
A code will be applied to each patient included. Medical data such as demography, Simplified Acute Physiological Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), procedures and complications during ICU stay will be collected.

Primary Outcome Measures :
  1. in ICU stay complications [ Time Frame: Within the first 28 days after ICU admission date ]
    Hospital acquired infections (epidemiology, risk factors, antibiotic susceptibility of pathogens), Organ failures (incidence, risks factors), Bleeding, Hemorrhage Intra-Cranial Hypertension, Brain Ischemia, Mechanical ventilation weaning, Extubation failure

Secondary Outcome Measures :
  1. Duration in mechanical ventilation [ Time Frame: in ICU (up to 90 days) ]
  2. ICU length of stay [ Time Frame: in ICU (up to 90 days) ]

Other Outcome Measures:
  1. Death [ Time Frame: in ICU (up to 180 days) ]

Biospecimen Retention:   Samples Without DNA
Plasma, serum, peripheral blood mononuclear cells, RNA

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   15 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients hospitalized in ICU for Non Traumatic Neuro-Vascular Diseases

Inclusion Criteria:

  • Non Traumatic Neuro-Vascular Diseases

Exclusion Criteria:

  • Consent withdrawal

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02714387

Layout table for location contacts
Contact: Karim Asehnoune, PhD, MD 02 40 08 73 80 ext 33
Contact: Antoine Roquilly, MD 02 40 08 73 80 ext 33

Layout table for location information
Angers University Hospital Recruiting
Angers, France, 49000
Contact: Sigismond Lasocki, PhD, MD   
Principal Investigator: Sigismond Lasocki, PhD, MD         
CHU de Brest La Cavale Blanche Recruiting
Brest, France, 29000
Contact: Olivier Huet, MD, PhD   
Principal Investigator: Olivier Huet, MD, PhD         
Nantes University Hospital Recruiting
Nantes, France, 44093
Contact: Karim Asehnoune, PhD, MD    02 40 08 73 80 ext 33   
Contact: Antoine Roquilly, MD    02 40 08 73 80 ext 33   
Poitiers University Hospital Recruiting
Poitiers, France, 86000
Contact: Olivier Mimoz, PhD, MD   
Contact: Claire Dahyot, MD   
Principal Investigator: Olivier Mimoz, PhD, MD         
Sub-Investigator: Claire Dahyot, MD         
Rennes University Hospital Recruiting
Rennes, France, 35000
Contact: Yannick Malledant, PhD, MD   
Contact: Philippe Seguin, PhD, MD   
Principal Investigator: Yannick Malledant, PhD, MD         
Sub-Investigator: Philppe Seguin, PhD, MD         
Tours University Hospital Recruiting
Tours, France, 37000
Contact: Martine Ferrandière, MD   
Principal Investigator: Martine Ferrandière, MD         
Sponsors and Collaborators
Nantes University Hospital
Layout table for investigator information
Study Chair: Karim Asehnoune, PhD, MD
Layout table for additonal information
Responsible Party: Nantes University Hospital Identifier: NCT02714387    
Other Study ID Numbers: RC12_0207 cohorte fiche 1
First Posted: March 21, 2016    Key Record Dates
Last Update Posted: September 15, 2017
Last Verified: September 2017
Keywords provided by Nantes University Hospital:
Non traumatic acute brain injury
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Injuries
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries